
Biovica International Investor Relations Material
Biovica International AB, a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. The company's focus is on prediction of treatment efficacy and prognosis, thereby providing physicians with objective decision-making tools that enable informed treatment choice. The company is based in Uppsala, Sweden
Upcoming events for
Q1 20232022-08-31
Latest company events
Ticker symbol
BIOVIC
Country
Sweden